Biotech

All Articles

OS Therapies refiles $6M IPO to money HER2 drug, preclinical ADCs

.OS Therapies will list on the NYSE American inventory substitution today by means of a $6.4 million...

ALX's waning CD47 action fee delivers supply spiraling down

.ALX Oncology's stage 2 gastric cancer cells response cost has actually damaged. After viewing its C...

Ionis axes eye illness from aim ats of Roche-partnered prospect after records dissatisfy

.One More of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed desires, c...

Biogen's CEO claimed no risky handle 2023. He prepares to be vibrant

.While Biogen's pharma peers are actually searching for late-stage resources along with little dange...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has actually been actually a biotech in search of a pipeline after it scrapped its...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually handed back civil liberties to an early Alzheimer's disease system to Denali Re...

Takeda water faucets new mind people oncology organization-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, firings and...

Vertex, beaten by AATD once again, goes down 2 resources on dispose of pile

.Tip's try to manage a rare genetic health condition has attacked another problem. The biotech threw...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Biotechnology's second-quarter profits record had not been short of large news. The company acc...

Galapagos pauses CAR-T cell therapy hearing over Parkinsonism case

.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T tissue treatment, pushing the b...